MELISSA LEPINE: Open Payments
NPI 1275973273 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 9 payments from 9 companies in 2025. Trend: 2023 $389 · 2024 $913 · 2025 $1,068
Food & beverage: $1,068
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $155 |
| Dexcom, Inc. | 1 | $150 |
| Janssen Biotech, Inc. | 1 | $146 |
| Amgen Inc. | 1 | $135 |
| KYOWA KIRIN, INC. | 1 | $118 |
| Neurocrine BioSciences, Inc. | 1 | $104 |
| Edwards Lifesciences Corporation | 1 | $88 |
| Lilly USA, LLC | 1 | $87 |
| Janssen Pharmaceuticals, Inc | 1 | $85 |
Products named: FREESTYLE LIBRE 3, DEXCOM G7 GSS (161), KRYSTEXXA, ZEPBOUND, SPRAVATO.
Industry payments across LA — which companies pay providers there.
